Dr. Shiva Gopal Vasishta’s career started shortly after he graduated from Government Medical College. Since then, he’s practiced neurology for over 40 years. He’s one of the most respected professionals in his field on the east coast. Currently, he’s practicing Neurology at Eastern Neurodiagnostic Associates in Voorhees, New Jersey.
Like all medical professionals, he completed his mandatory medical residency before getting a formal position. He worked at several facilities during his early years, learning from numerous mentors. Finally, he settled at Eastern Neurodiagnostic. He practice supports Spanish as well as English. He’s also consistently updated on the latest neurology-related therapies and treatments.
An interesting new study revealed the benefits of stem-cell transplants as a possible treatment for multiple sclerosis (MS). The study, referred to as HALT-MS, looking at the results of high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT). The results were astonishing.
The study took place over a five-year period. It studied the effects of a one-time treatment on volunteering patients. The treatment involves the stem cell transplant of one’s own blood cells. If performed at the correct time, it yielded long-term remission and showed no progression of symptoms, relapse, or new brain lesions.
The new study could be the new option for MS patients. With more study results comes better conclusions. So far, the results show a significantly higher success rate than the MS drugs currently used by most patients. Over 60 percent of participants got progressively better in a shorter time frame.
The clinical patients that participated ranged from age 26 to 52. All were previously using their current MS medicine but weren’t getting better. HDIT/HCT helped nearly 70 percent of them achieve a health status higher than before the treatment.